- Home
- MFA vs CLDX Comparison
MFA vs CLDX Comparison
Compare MFA & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- CLDX
- Stock Information
- Founded
- MFA 1997
- CLDX N/A
- Country
- MFA United States
- CLDX United States
- Employees
- MFA N/A
- CLDX N/A
- Industry
- MFA Real Estate Investment Trusts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MFA Real Estate
- CLDX Health Care
- Exchange
- MFA Nasdaq
- CLDX Nasdaq
- Market Cap
- MFA 1.1B
- CLDX 1.3B
- IPO Year
- MFA N/A
- CLDX 2008
- Fundamental
- Price
- MFA $10.27
- CLDX $18.15
- Analyst Decision
- MFA Buy
- CLDX Buy
- Analyst Count
- MFA 5
- CLDX 8
- Target Price
- MFA $13.20
- CLDX $54.29
- AVG Volume (30 Days)
- MFA 1.1M
- CLDX 749.8K
- Earning Date
- MFA 05-05-2025
- CLDX 05-05-2025
- Dividend Yield
- MFA 13.97%
- CLDX N/A
- EPS Growth
- MFA 78.26
- CLDX N/A
- EPS
- MFA 0.82
- CLDX N/A
- Revenue
- MFA $279,608,000.00
- CLDX $7,020,000.00
- Revenue This Year
- MFA N/A
- CLDX N/A
- Revenue Next Year
- MFA $8.97
- CLDX $27.01
- P/E Ratio
- MFA $12.57
- CLDX N/A
- Revenue Growth
- MFA 19.47
- CLDX 1.99
- 52 Week Low
- MFA $9.36
- CLDX $17.63
- 52 Week High
- MFA $13.45
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- MFA 35.41
- CLDX 34.76
- Support Level
- MFA $10.64
- CLDX $19.48
- Resistance Level
- MFA $10.89
- CLDX $20.38
- Average True Range (ATR)
- MFA 0.21
- CLDX 1.04
- MACD
- MFA -0.06
- CLDX -0.02
- Stochastic Oscillator
- MFA 29.21
- CLDX 12.32
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.